Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Adenoviridae Infections × liposomal doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Ovarian Neoplasms 5 Fallopian Tube Neoplasms 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Carcinoma, Ovarian Epithelial 3 Sarcoma, Ewing 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Vaccinia 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Rhabdomyosarcoma 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Cancer Recurrent 1 Osteosarcoma 1 Neoplasm Metastasis 1 Low Grade Serous Ovarian Cancer 1 Leiomyosarcoma 1 Hodgkin Disease 1 HER2-negative Breast Cancer 1 Endometrial Neoplasms 1 Adenoviridae Infections 1 Adenocarcinoma, Clear Cell 1

Interventions

Cell Count 2 pembrolizumab 1 liposomal doxorubicin 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05271318 2025-11-03

PROTA

TILT Biotherapeutics Ltd.

Phase 1/2 Recruiting

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡